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Abstract
Background: Based on recent findings and our own impressions we took a closer look at the relationship between
(inter)ictal photophobia and psychometric variables in migraine patients with photophobia.
Findings: For this study we included 29 (27 female) migraine patients and 31 (18 female) controls with a mean age
of 31.6 ± 12.5 years and 24.0 ± 4.1 years, respectively. All participants filled out the Depression Anxiety Stress Scale
(DASS).
Interictal photophobia in patients was significantly higher than photophobia in controls (p = .001). Patients showed
statistically significantly higher levels of depressive symptoms (p < .001), anxiety symptoms (p < .001) and stress
(p < .001) than controls. Among all participants, (interictal) photophobia correlated positively with age (rho = .318,
p = .013) as well as with the levels of depressive symptoms (rho = .459, p < .001), anxiety symptoms (rho = .346,
p = .008) and stress (rho = .368, p = .005), but not with gender. In the patients, ictal photophobia correlated
positively with age (rho = .473, p = .01) and interictal photophobia (rho = .423, p = .022). Linear regression analysis
revealed only a trend towards statistical significance for (interictal) photophobia as a predictor for the level of
depressive symptoms (rho = .457, p = 0.056) in the whole sample.
Conclusions: Considering higher levels of photophobia in depression and the comorbidity of migraine and
depression, it might be possible that depression contributes to interictal photophobia in patients with migraine.
The same may be true for anxiety and stress. Both are also related to migraine and their possible impact on
photophobia in migraine may be explained by pupillary dysfunction.
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Introduction
Photophobia is a common symptom of migraine attacks
experienced by up to 80% of the patients. The preva-
lence seems to increase with age [1–3]. Sensitivity to
light is not limited to the headache phase, but frequently
is also present in the premonitory phase as well as after
headache has subsided [1]. Measuring quantitative
thresholds for discomfort and pain with monocular and
binocular light stimuli, Vanagaite et al. [4] found that
migraine patients were more photophobic during attacks
than outside attacks and that they were more sensitive
to light than controls even between attacks. Main et al.
[5] reported significantly lower interictal light discomfort
thresholds in migraineurs compared to controls. Func-
tional neuroimaging showed more activation of the
extrastriate visual cortex in migraine patients with
photophobia compared to those without photophobia
during the premonitory phase of a migraine attack [6, 7].
The comorbidity of migraine with depression, anxiety
and stress is well known and was investigated recently in
a population-based study by Risal et al. which
highlighted the negative consequences of these co-
morbidities on the quality of life in migraine patients [8].
In this context it appears noteworthy that patients with
psychiatric disorders often exhibit affective temperament
dysregulation and suicidal behaviors [9]. These specific
characteristics may significantly contribute to the psy-
chocial impairment and altered quality of life of these
subjects. A possible relation between depression and
photophobia has been reported already in 1989 [10]. Re-
cently Llop et al. [11] and Anagnostou et al. [12] investi-
gated the association of migraine and photophobia.
While the former authors [11] found that photophobia
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might predispose migraineurs for psychiatric comorbidi-
ties, the latter showed that photophobia may not exclu-
sively be related to migraine [12].
During the patient recruitment for a case-control
functional magnetic resonance imaging (fMRI) study on
the effects of repeated flicker light exposure on photo-
phobia in migraine patients (KLI 455, Austrian Science
Fund, FWF) we noticed that the number of patients with
significant psychiatric comorbidities exceeded our
expectations.
Hence, we decided to take a closer look at the relation-
ship between (inter)ictal photophobia and psychometric
variables in the subjects screened for participation in our
fMRI study.
Findings
We included patients with migraine and migraine-free
controls screened for possible participation in a pro-
spective study on the effects of repeated flicker light ex-
posure on the level of photophobia (KLI 455, Austrian
Science Funds (FWF)).
The participants’ age had to be between 18 to 45 years.
Inclusion criteria for patients comprised (1) migraine
without aura according to the criteria of the beta-version
of the third edition of the International Classification of
Headache Disorders (ICHD-3 beta) [13], (2) 1–4 days
with migraine per month in the 3 months preceding
study inclusion, (3) an intensity of interictal photophobia
of 2–6 on a numeric rating scale (NRS, range 0 to 10)
and (4) an intensity of ictal photophobia of >4. Controls
had to fulfil the following inclusion criteria: (1) no per-
sonal or family history of migraine and (2) photophobia
<2 on the NRS. Exclusion criteria for both groups were:
(1) any other recurrent current or previous headache
disorder apart from infrequent tension-type headache,
and (2) current or previous medication overuse. All par-
ticipants completed the 21-item version of the Depres-
sion Anxiety Stress Scale (DASS) [14]. It consists of
three self-report scales (7 items per scale) designed to
measure the negative emotional states of depression,
anxiety and stress. The depression scale assesses
dysphoria, hopelessness, devaluation of life, self-
deprecation, lack of interest/involvement, anhedonia,
and inertia. The anxiety scale assesses autonomic
arousal, skeletal muscle effects, situational anxiety, and
subjective experience of anxious affect. The stress scale
is sensitive to levels of chronic non-specific arousal. It
assesses difficulty relaxing, nervous arousal, and being
easily upset/agitated, irritable/over-reactive and impa-
tient. Subjects are asked to use 4-point severity/fre-
quency scales to rate the extent to which they have
experienced each state over the past week. Scores for de-
pression, anxiety and stress are calculated by summing
the scores for the relevant items. Paricipants were
excluded from the flicker light study, if the DASS de-
pression subscore was ≥7 points and/or the anxiety sub-
score was ≥6 points.
So far, we have screened 29 (27 female) migraine pa-
tients and 31 (18 female) controls (p = .005) with a mean
age of 31.6 ± 12.5 years and 24.0 ± 4.1 years (p = .74), re-
spectively. We were astounded that 10 (40%) migraine
patients had to be excluded from the flicker light study,
because the DASS depression subscore was ≥7 and/or
the anxiety subscore was ≥6, while none of the controls
exceded these cut-off scores (p < 0.001).
Interictal photophobia was <2, 2–6, and >6 in 7, 19, and
3 patients; ictal photopobia was ≤4 in 1 and >4 28 patients.
Ten controls gave photophobia ≥2. Interictal photophobia
in patients was significantly higher than photophobia in
controls (Table 1, p = .001). Patients and controls also dif-
fered statistically significantly regarding their levels of de-
pressive symptoms (p < .001), anxiety symptoms (p < .001)
and stress (p < .001) on the DASS (Table 1).
To further evaluate the impact of photophobia we per-
formed multivariate correlation analyses including age,
gender and DASS scores of depressive symptoms, anx-
iety symptoms and stress as well as linear regression
analyses using each of the three psychiatric domains as
dependent variables. Both calculations were done for the
entire sample of participants (n = 60) and separately for
patients with migraine (n = 29) and controls (n = 31).
Among all participants, (interictal) photophobia corre-
lated positively with age (rho = .318, p = .013) as well as
with the DASS subscores for depressive symptoms (rho
= .459, p < .001), anxiety symptoms (rho = .346, p = .008)
and stress (rho = .368, p = .005), but not with gender. In
the patients, the only statistically significant correlations
were those of ictal photophobia with age (rho = .473,
p = .01) and interictal photophobia (rho = .423, p = .022).
Ictal photophobia did not correlate with gender and
DASS scores. Interictal photophobia did not show any
statistically significant correlations in patients and the
same was true for photophobia in controls.
Linear regression analysis revealed only a trend towards
statistical significance for (interictal) photophobia as a pre-
dictor for the level of depressive symptoms (rho = .457,
p = 0.056) in the whole sample. In separate analyses of
patients and controls, none of the factors age, gender,
(interictal) photophobia and ictal photophobia (for mi-
graine patients only) significantly predicted the levels of
depressive symptoms, anxiety symptoms and stress.
Discussion
This analysis of 60 subjects screened for participation in
a prospective study on the effects of repeated flicker
light exposure on the level of photophobia revealed a
trend towards a relation of photophobia to the severity
of depressive symptoms, anxiety symptoms and stress.
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However, this was only true for the total group of mi-
graine patients and controls and not for each of the two
study groups separately.
Accordingly, we failed to replicate the findings of Llop
et al. [11]. These authors applied the Beck Depression
Inventory (BDI-II) and the Beck Anxiety Inventory (BAI)
in migraine patients with and without interictal photo-
phobia and in migraine-free controls and included 16
subjects in each of the three groups. BDI-II and BAI
scores were statistically significantly higher in patients
with interictal photophobia than in those without inter-
ictal photophobia and in migraine-free controls.
The conflicting findings in our study and that of Llop
and co-workers [11] may be explained by the different
questionnaires (DASS vs. BDI-II and BAI) and by differ-
ences in age (31.6 vs 51 years). The latter might be more
relevant following the hypothesis of Llop et al. [11] that
interictal photophobia may increase with age as part of a
central sensitization process. Similarly Grassini and Nor-
din [15] hypothesized the central sensitization may ex-
plain depression, anxiety, stress, functional somatic
syndromes, and somatization in patients with migraine.
Considering higher levels of photophobia in depression
[16] and the comorbidity of migraine and depression [17],
it might be possible that depression contributes to interic-
tal photophobia in patients with migraine. The same may
be true for anxiety and stress. Both are also related to mi-
graine [18] and their possible impact on photophobia in
migraine may be explained by pupillary dysfunction [18–
20]. In anxiety disorders [18, 19] and posttraumatic stress
disorder [20] exaggerated pupillary dilation in response to
stressful and negative stimuli is a reliable autonomous
marker, even beyond the clinically active phase of the con-
dition [20]. In contrast, a most recent abstract [21]
showed a sympathetically-mediated association between
interictal photophobia and pupil size in patients with mi-
graine. In this study, lower photophobia thresholds were
related to smaller dark-adapted pupil size and impaired
re-dilation following a brief pulse of light. Re-dilation was
least pronounced in the most severely affected patients.
These findings suggest a physiological coping mechanism
to a lowered threshold for light sensitivity in patients with
migraine. Recently, prolonged neuronal suppression after
visual adaptation in migraine patients has been reported
[22]. One may speculate that pupillary dilation related to
anxiety and stress counteracts this coping mechanism and
thus causes increased photophobia. Finally, tizanidine, a
drug used in migraine prophylaxis, has been shown to re-
duce pain-induced pupillary dilation [23], but the effect of
tizanidine on photophobia in migraine has not been
assessed.
Our study is limited by the small sample size emphasiz-
ing the preliminary and exploratory nature of our main
findings. It may also have been biased by the predomin-
ance of the female gender in the patient group compared
to the controls. The inclusion of another control group
consisting of migraine patients without interictal photo-
phobia would have further strengthened our data.
In conclusion, the relation of photophobia, pupillary
function, and psychiatric comorbidities in patients with
migraine is not well understood and deserves further
and larger studies.
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Table 1 Clinical data of migraine patients and controls
Patients (n = 29) Controls (n = 31) p-value
Age mean ± SD 31.6 ± 12.5 24.0 ± 4.1 .74
range 19–68 20–29
Gender (m:f) n 2:27 12:18 .005*
(Interictal) photophobia (NRS) mean ± SD 3.1 ± 2.1 1.5 ± 1.8 .001+
range 0–8 0–7
Ictal photophobia (NRS) mean ± SD 7.3 ± 1.8 N/A –
range 3–7 N/A
DASS depression score mean ± SD 3.6 ± 4.0 0.7 ± 1.1 <.001+
range 0–15 0–5
DASS anxiety score mean ± SD 4.0 ± 4.0 0.4 ± 0.8 <.001+
range 0–14 0–3
DASS stress sore mean ± SD 6.0 ± 5.2 1.4 ± 1.9 <.001+
range 0–19 0–7
DASS Depression Anxiety Stress Scale, N/A not applicable, NRS numeric rating scale, SD standard deviation. +Mann-Whitney-U-test; *Chi-Quadrat-test
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